$USNA

USANA (USNA) Q2 2026 Earnings Call Transcript

USANA (USNA) held its Q2 2026 earnings call. Management said Core Nutritional was stable, with Mainland China showing renewed strength. The company recorded a preliminary $29 million noncash goodwill impairment and $9 million income tax expense on a $19 million pretax loss. USANA ended the quarter with $169 million cash, zero debt, and $20 million free cash flow, and lowered its fiscal 2026 outlook due to HYA DTC marketing and Rise net sales.

Original reporting
Published Aug 12, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 1:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
USANA (USNA) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$USNABearishMed
01

Why it matters

Key new disclosures are a $29M preliminary noncash goodwill impairment tied to lower-than-expected performance and forecast changes, plus a guidance reduction driven by higher DTC digital marketing costs and lower near-term Rise Wellness net sales. Management also reiterates core nutritional stability, China momentum, and a strong cash position (debt-free, $169M cash, $20M free cash flow).

02

Market read

Traders get a near-term earnings risk update via lowered full-year outlook and impairment, with partial offset from stable core nutritional performance and strong liquidity.

03

What to watch

The call attributes the Rise Wellness full-year net sales reduction to a resolved packaging issue, implying the guidance cut may be partially reversible; traders should watch for any follow-up on marketing efficiency and subscriber growth trends.

Relevance 8/10Novelty 7/10Timing: updated fiscal 2026 outlook discussed on the earnings call

Background

USANA’s Q2 2026 earnings call discusses segment performance across Core Nutritional, HYA, and Rise Wellness, including accounting impacts and an updated fiscal 2026 outlook.

Company-level read

Ticker impact

$USNABearishMedium confidence
Context

USANA guided fiscal 2026 lower, citing a tougher, more expensive HYA direct-to-consumer digital marketing environment and lower Rise Wellness net sales.

Expected impact

Likely negative near-term bias as the lowered outlook and impairment raise earnings risk, partially offset by stable core nutritional performance and a strong, debt-free cash position.

Evidence & confidence

The call includes a $29M noncash goodwill impairment and explicit full-year outlook reduction, both typically weigh on sentiment. However, management also emphasizes core nutritional stability, $169M cash, zero debt, and ongoing retail and international traction, which can limit downside.

Market effects

Highlights ongoing margin and growth sensitivity for nutrition brands to DTC digital marketing costs, which can influence sentiment across health and wellness direct-to-consumer models.

China segment strength (Greater China uptick) is referenced as a stabilizer, suggesting regional demand resilience despite consolidated outlook pressure.

International expansion and retail channel traction are emphasized, but near-term guidance reduction signals execution and cost headwinds remain global.

Counterpoint

The lowered outlook is framed as near-term timing rather than long-term conviction, and the company remains debt-free with $169M cash, which may reduce balance-sheet risk and support a rebound if marketing efficiency improves.

Key entities

  • USANA

    Discussed Q2 results, a $29M goodwill impairment, and a lowered fiscal 2026 outlook due to HYA DTC marketing headwinds and Rise Wellness net sales softness.

  • HYA

    Children’s health and wellness brand; management cites tougher, more expensive DTC digital marketing environment impacting second-half net sales and subscriber growth.

  • Rise Wellness

    Packaging issue affected execution; issue resolved, but full-year HYA net sales expected lower than previously anticipated.

Related articles

$USNAMedAI 8/10

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences (NYSE:USNA) reported Q2 updates including a $29 million preliminary non-cash goodwill impairment tied to its Hiya reporting unit and $9 million income tax expense on a $19 million pre-tax loss. Management cited about $30 million to $40 million top-line pressure and $4 million to $5 million margin pressure, plus a Rise packaging disruption. USANA ended with $169 million cash and no debt.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N

$DYHighAI 8/10

Why is Dycom Industries stock sliding today?

Dycom Industries (DY) stock fell 5.5% in pre-market trading to $332.50 despite beating Q2 earnings and revenue estimates. The decline followed cautious Q3 guidance, with EPS midpoint below consensus. Revenue guidance met expectations. The company authorized a $150M share buyback and was added to Raymond James' Analyst Current Favorites list. The broader market had no impact, and the move was driven by company-specific factors.